Literature DB >> 6446234

Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients.

J T Lie.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 6446234     DOI： 10.1016/0002-8703(80)90277-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  53 in total

1.  RITA trial protocol.

Authors:  K J Beatt
Journal:  Br Heart J       Date:  1990-07

2.  Third degree heart block in acromegaly.

Authors:  T T Tan; H B Gangaram; K Yusoff; B A Khalid
Journal:  Postgrad Med J       Date:  1992-05       Impact factor: 2.401

3.  Doppler echocardiographic patterns in patients with acromegaly.

Authors:  M Terzolo; L Avonto; C Matrella; R Pozzi; S Luceri; G Borretta; F Pecchio; G Ugliengo; G P Magro; G Reimondo
Journal:  J Endocrinol Invest       Date:  1995-09       Impact factor: 4.256

4.  Resolution of acromegalic cardiomyopathy in mild acromegalic physical abnormality after short-term octreotide therapy.

Authors:  Myung-Woo Hwang; Akira Shimatsu; Yoshio Sasaki; Hiroyuki Ayukawa; Katsura Inenaga; Rei Takeoka; Tomoyuki Iwase; Chuichi Kawai
Journal:  Heart Vessels       Date:  2007-05-21       Impact factor: 2.037

Review 5.  Acromegaly.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

6.  Atrial conduction times and left atrium mechanical functions in patients with active acromegaly.

Authors:  A Ilter; A Kırış; Ş Kaplan; M Kutlu; M Şahin; C Erem; N Civan; F Kangül
Journal:  Endocrine       Date:  2014-07-15       Impact factor: 3.633

7.  Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues.

Authors:  A Comunello; F Dassie; C Martini; E De Carlo; R Mioni; M Battocchio; A Paoletta; F Fallo; R Vettor; P Maffei
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

8.  Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction.

Authors:  Marta Ragonese; Angela Alibrandi; Gianluca Di Bella; Ignazio Salamone; Soraya Puglisi; Oana Ruxandra Cotta; Maria Luisa Torre; Francesco Ferrau; Rosaria Maddalena Ruggeri; Francesco Trimarchi; Salvatore Cannavo
Journal:  Endocrine       Date:  2013-11-27       Impact factor: 3.633

9.  The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly.

Authors:  Laura De Marinis; Antonio Bianchi; Gherardo Mazziotti; Marco Mettimano; Domenico Milardi; Alessandra Fusco; Vincenzo Cimino; Giulio Maira; Alfredo Pontecorvi; Andrea Giustina
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

10.  Left ventricular synchronicity is impaired in patients with active acromegaly.

Authors:  Abdulkadir Kırış; Cihangir Erem; Oğuzhan Ekrem Turan; Nadim Civan; Gülhanım Kırış; Irfan Nuhoğlu; Abdulselam Ilter; Halil Onder Ersöz; Merih Kutlu
Journal:  Endocrine       Date:  2012-12-20       Impact factor: 3.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.